Adia Nutrition, Inc. (ADIA)

Market Cap	15.10M +71.9%
Revenue (ttm)	805.02K +58.7%
Net Income	-441.77K
EPS	-0.00
Shares Out	94.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1600
Previous Close	0.1600
Day's Range	0.1600 - 0.1600
52-Week Range	0.0227 - 0.2777
Beta	-8.57
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Adia Nutrition

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1999
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ADIA

Financial Performance

In 2025, Adia Nutrition's revenue was $700,508, an increase of 10879.75% compared to the previous year's $6,380. Losses were -$395,464, 118.4% more than in 2024.